Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) has a MoatMap StockRank of 74/100 based on Quality (82/100), Value (46/100), and Momentum (30/100) factor scores. The current signal is BUY. Mindray is China's premier medical device champion, boasting high ROIC, strong pricing power, and a massive reinvestment runway. The company is a prime beneficiary of China's medical infrastructure upgrade and domestic substitution policy, while successfully expanding its footprint in Europe and the Americas. Its scale allows it to share economics with hospital systems globally, offering high-quality diagnostics at lower total cost of ownership.
Shenzen Mindray Bio-Medical Electronics Co., Ltd. is China's largest medical device manufacturer, specializing in patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. The company holds a dominant domestic market position and has established a formidable global footprint, competing directly with multinational medtech giants. It is characterized by its massive R&D investment, highly diversified product portfolio, and strong cost-performance advantages in global healthcare markets.
| Price | $20.99 |
| Market Cap | $27.2B |
| P/E (TTM) | 22.31 |
| P/E (Forward) | 15.96 |
| Price/Book | 4.36 |
| Return on Equity | 18.5% |
| Return on Invested Capital | 20.3% |
| Debt/Equity | 0.77 |
| Gross Margin | 59.2% |
| Operating Margin | 33.3% |
| Revenue Growth | 1.4% |
| Dividend Yield | 4.3% |
| Free Cash Flow | $131M |
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. operates in the Medical Devices industry, part of the Healthcare sector (China).